R2 Technology and Swedish IT and medical technology company Sectra Imtec are customizing R2's computer-aided detection technology for use with the Sectra MicroDose digital mammography system. The focus of the agreement is R2's ImageChecker CAD
R2 Technology and Swedish IT and medical technology company Sectra Imtec are customizing R2's computer-aided detection technology for use with the Sectra MicroDose digital mammography system. The focus of the agreement is R2's ImageChecker CAD technology, which is designed to assist radiologists in the early detection of breast cancer and has already been incorporated into digital mammography systems from other vendors, including GE Medical Systems. The two companies plan to integrate CAD not only into the MicroDose mammography system but also into Sectra PACS for Breast Imaging. Under the agreement, Sectra will have exclusive worldwide distribution rights for three years to R2's CAD technology as applied to Sectra's MicroDose mammography system. The system is based on a highly efficient digital detector technology, which promises to reduce radiation dose by 80% or more without affecting image quality. Sectra recently invested more than $11 million in Stockholm-based Mamea Imaging, developer of the novel detector technology and ergonomic imaging stand that make up Sectra's low-dose digital mammography system (SCAN 1/8/04).
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.